Top-Rated StocksTop-RatedMost-Downgraded StocksMost-DowngradedNYSE:EVH Evolent Health (EVH) Stock Price, News & Analysis $10.67 -0.04 (-0.37%) As of 01:03 PM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends About Evolent Health Stock (NYSE:EVH) 30 days 90 days 365 days Advanced Chart View Price History Chart DataSkip Price History Chart Get Evolent Health alerts:Sign Up Key Stats Today's Range$10.38▼$11.0350-Day Range$9.60▼$12.6152-Week Range$9.45▼$35.00Volume2.27 million shsAverage Volume2.15 million shsMarket Capitalization$1.24 billionP/E RatioN/ADividend YieldN/APrice Target$17.79Consensus RatingBuy Company OverviewEvolent Health, Inc., through its subsidiary, Evolent Health LLC, offers specialty care management services in oncology, cardiology, and musculoskeletal markets in the United States. The company provides platform for health plan administration and value-based business infrastructure. It offers administrative services, such as health plan services, pharmacy benefits management, risk management, analytics and reporting, and leadership and management; and Identifi, a proprietary technology system that aggregates and analyzes data, manages care workflows, and engages patients. In addition, the company provides holistic total cost of care management. Evolent Health, Inc. was founded in 2011 and is headquartered in Arlington, Virginia.Read More… Evolent Health Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreEVH MarketRank™: Evolent Health scored higher than 54% of companies evaluated by MarketBeat, and ranked 382nd out of 656 stocks in the computer and technology sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.5 / 5Analyst RatingBuy Consensus RatingEvolent Health has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 12 buy ratings, 1 hold rating, and no sell ratings.Amount of Analyst CoverageEvolent Health has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.Read more about Evolent Health's stock forecast and price target. Earnings and Valuation0.0 / 5Proj. Earnings Growth-63.64% Earnings GrowthEarnings for Evolent Health are expected to decrease by -63.64% in the coming year, from $0.22 to $0.08 per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Evolent Health is -11.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Evolent Health is -11.87, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioEvolent Health has a P/B Ratio of 1.14. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.Read more about Evolent Health's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted9.57% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Evolent Health has recently decreased by 1.15%, indicating that investor sentiment is improving. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldEvolent Health does not currently pay a dividend.Dividend GrowthEvolent Health does not have a long track record of dividend growth. Sustainability and ESGN/AEnvironmental ScoreN/A Percentage of Shares Shorted9.57% of the outstanding shares of Evolent Health have been sold short.Short Interest Ratio / Days to CoverEvolent Health has a short interest ratio ("days to cover") of 4.Change versus previous monthShort interest in Evolent Health has recently decreased by 1.15%, indicating that investor sentiment is improving. News and Social Media3.1 / 5News Sentiment0.67 News SentimentEvolent Health has a news sentiment score of 0.67. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Computer and Technology companies.News Coverage This WeekMarketBeat has tracked 19 news articles for Evolent Health this week, compared to 5 articles on an average week.Search Interest4 people have searched for EVH on MarketBeat in the last 30 days. This is an increase of 33% compared to the previous 30 days.MarketBeat Follows5 people have added Evolent Health to their MarketBeat watchlist in the last 30 days. This is an increase of 25% compared to the previous 30 days. Company Ownership0.0 / 5Insider TradingN/A Insider Buying vs. Insider SellingIn the past three months, Evolent Health insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 1.60% of the stock of Evolent Health is held by insiders.Read more about Evolent Health's insider trading history. Receive EVH Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Evolent Health and its competitors with MarketBeat's FREE daily newsletter. Email Address EVH Stock News HeadlinesKeyBanc Sticks to Their Buy Rating for Evolent Health (EVH)February 21 at 5:51 AM | markets.businessinsider.comEvolent Health misses Q4 estimates, shares drop on weak guidanceFebruary 21 at 12:26 AM | in.investing.comEx-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000”Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?February 21, 2025 | Colonial Metals (Ad)Evolent Health reports Q4 EPS (2c), consensus 1cFebruary 21 at 12:26 AM | markets.businessinsider.comEvolent Health sees Q1 revenue $440M-$447M, consensus $592.1MFebruary 21 at 12:26 AM | markets.businessinsider.comEvolent Health (NYSE:EVH) Misses Q4 Sales TargetsFebruary 21 at 12:26 AM | msn.comEvolent Health, Inc. (EVH) Q4 2024 Earnings Call TranscriptFebruary 20 at 8:31 PM | seekingalpha.comEvolent Announces Fourth Quarter and Full Year 2024 ResultsFebruary 20 at 4:10 PM | prnewswire.comSee More Headlines EVH Stock Analysis - Frequently Asked Questions How have EVH shares performed this year? Evolent Health's stock was trading at $11.25 at the beginning of the year. Since then, EVH stock has decreased by 4.6% and is now trading at $10.7270. View the best growth stocks for 2025 here. How were Evolent Health's earnings last quarter? Evolent Health, Inc. (NYSE:EVH) posted its quarterly earnings data on Thursday, February, 20th. The technology company reported $0.03 EPS for the quarter, missing analysts' consensus estimates of $0.38 by $0.35. The technology company had revenue of $646.54 million for the quarter, compared to analyst estimates of $650.92 million. Evolent Health had a positive trailing twelve-month return on equity of 6.30% and a negative net margin of 2.93%. When did Evolent Health IPO? Evolent Health (EVH) raised $150 million in an initial public offering on Friday, June 5th 2015. The company issued 10,000,000 shares at a price of $14.00-$16.00 per share. J.P. Morgan and Goldman Sachs served as the underwriters for the IPO and Wells Fargo Securities, William Blair, SunTrust Robinson Humphrey and Leerink Partners were co-managers. Who are Evolent Health's major shareholders? Top institutional investors of Evolent Health include Vanguard Group Inc. (9.58%), Wellington Management Group LLP (8.95%), Engaged Capital LLC (4.64%) and Cadian Capital Management LP (4.48%). Insiders that own company stock include Frank J Williams, Seth Blackley, Daniel Joseph Mccarthy, John Paul Johnson, Jonathan Weinberg, Emily Ann Rafferty, Diane Holder, Cheryl Scott, Mary Bridget Duffy and Steve Tutewohl. View institutional ownership trends. How do I buy shares of Evolent Health? Shares of EVH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Evolent Health own? Based on aggregate information from My MarketBeat watchlists, some other companies that Evolent Health investors own include Humana (HUM), American Water Works (AWK), Voyager Therapeutics (VYGR), Waste Connections (WCN), The RMR Group (RMR), DiamondRock Hospitality (DRH) and Southern First Bancshares (SFST). Company Calendar Last Earnings2/20/2025Today2/21/2025Next Earnings (Estimated)5/08/2025Fiscal Year End12/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNYSE SectorComputer and Technology Industry Management services Sub-IndustryBusiness Services Current SymbolNYSE:EVH CUSIPN/A CIK1628908 Webwww.evolenthealth.com Phone(571) 389-6000Fax571-389-6001Employees4,700Year FoundedN/APrice Target and Rating Average Stock Price Target$17.92 High Stock Price Target$35.00 Low Stock Price Target$12.00 Potential Upside/Downside+67.3%Consensus RatingBuy Rating Score (0-4)3.00 Research Coverage13 Analysts Profitability EPS (Most Recent Fiscal Year)($0.91) Trailing P/E RatioN/A Forward P/E Ratio48.70 P/E GrowthN/ANet Income$-113,040,000.00 Net Margins-2.93% Pretax Margin-3.54% Return on Equity6.30% Return on Assets2.57% Debt Debt-to-Equity Ratio0.58 Current Ratio1.04 Quick Ratio1.04 Sales & Book Value Annual Sales$1.96 billion Price / Sales0.64 Cash Flow$1.82 per share Price / Cash Flow5.89 Book Value$9.38 per share Price / Book1.14Miscellaneous Outstanding Shares116,560,000Free Float114,699,000Market Cap$1.25 billion OptionableOptionable Beta1.45 Social Links Metaverse Stocks And Why You Can't Ignore ThemThinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.Get This Free Report This page (NYSE:EVH) was last updated on 2/21/2025 by MarketBeat.com Staff From Our PartnersCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredNVDA Crash UpdateAn overseas AI rival sent shockwaves through the U.S. tech market last week... Leaving millions of investor...Chaikin Analytics | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredHas Trump finally met his match?Dylan Jovine predicted the 2008 crash over a year before it happened. Folks who listened to him had the chance...Behind the Markets | Sponsored My 2025 AI BlueprintI first recommended Bitcoin at $300 in 2013 … before it went up 33,645%. Now, I am revealing my 2025 AI Blu...Weiss Ratings | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Evolent Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Evolent Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.